Jun Qi Lab
427 posts

Jun Qi Lab
@JunQiLab
Chemical Biology lab @HarvardMed and @DanaFarber. We use a multidisciplinary approach to study biological roles of epigenetic proteins & transcription factors.




Hope is powerful. Research is lifesaving. 🙏 Your support helps fund groundbreaking discoveries for children battling cancer. Read how it’s making a difference in our latest edition of Research Outcomes: ow.ly/sNel50YhTUk

New research in @angew_chem by @DanaFarber’s @JunQiLab reveals a novel chemical biology approach to achieving selective targeted protein degradation using proteosome cap region proteins directly in addition to the current PROTAC strategy, which could aid in developing therapies and cancer drugs. ➡️ bit.ly/4rbilu9







Our collaborative work with Prof. Mo Movassaghi at @chemistryMIT and @FilbinMariella is now online @acsJACS @ACSPublications. Thrilled to work as chemical biology part to explore therapeutic potential of these awesome nature compounds from Mo's lab. pubs.acs.org/doi/10.1021/ja…






Can we have a biotinylated and inactive version of the HDAC1/2 inhibitor? How do you do Chem-seq, Jun? In the end, we were able to follow our observations and publish these findings thanks to collaborative science fostered by @DanaFarber @DanaFarberNews



Proof-of-concept: Epigenetic reprogramming could one day be a new therapeutic path in colorectal cancer. @Nilay_Sethi explains how histone acetylation shapes CRC cell fate in this @AGA_Gastro study: bit.ly/46gS7z1

Proof-of-concept: Epigenetic reprogramming could one day be a new therapeutic path in colorectal cancer. @Nilay_Sethi explains how histone acetylation shapes CRC cell fate in this @AGA_Gastro study: bit.ly/46gS7z1









Had a great time visiting Dana-Farber Cancer Institute and sharing our work on chromatin mechanisms in cancer! Huge thanks to @JunQiLab for the invitation and generous hosting. So much fun reconnecting with mentor & old friends, making new ones, & a full day of amazing science!

Dana-Farber has elected the largest cohort of physician-investigators to the 2025 class of ASCI @DanaFarber @FilbinMariella @ManciasLab @Oser_Lab @AbbyRosenbergMD @Nilay_Sethi @srviswanathan oncodaily.com/blog/dana-farb… #ASCI #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews


